Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Blood Transfusion = Trasfusione Del Sangue|May 3, 2016
The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subsetKatia Chieregato, Cristina Zanon, Silvia Castegnaro, et al.Stem Cell Research & Therapy|July 15, 2016
Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureGiuseppe Astori, Eliana Amati, Franco Bambi, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 9, 2015
Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assayKatia Chieregato, Alberta Alghisi, Carlo Borghero, et al.American Journal of Translational Research|July 1, 2010
Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal productsGiuseppe Astori, Sabrina Soncin, Viviana Lo Cicero, et al.Heliyon|February 8, 2021
A flow cytometric assay for the quantification of MSC lysis by peripheral blood mononucleated cellsKatia Chieregato, Martina Bernardi, Alberta Alghisi, et al.Stem Cell Research & Therapy|January 18, 2018
High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sourcesEliana Amati, Omar Perbellini, Gianluca Rotta, et al.Journal of Translational Medicine|May 21, 2017
Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approachFrancesco Agostini, Jerry Polesel, Monica Battiston, et al.Blood Cells, Molecules & Diseases|July 24, 2012
A study on mutual interaction between cytokine induced killer cells and umbilical cord-derived mesenchymal cells: Implication for their in-vivo useKatia Chieregato, Elena Albiero, Silvia Castegnaro, et al.Plos One|January 3, 2018
In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cellsSabrina Sella, Valentina Adami, Eliana Amati, et al.Cytotherapy|May 23, 2016
Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?Ander Izeta, Concha Herrera, Rosario Mata, et al.Pageof 4